Gateway Investment Advisers LLC lowered its holdings in HCA Healthcare Inc (NYSE:HCA) by 5.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 280,878 shares of the company’s stock after selling 17,306 shares during the quarter. Gateway Investment Advisers LLC’s holdings in HCA Healthcare were worth $24,672,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. Argent Capital Management LLC lifted its holdings in HCA Healthcare by 1.2% in the second quarter. Argent Capital Management LLC now owns 4,370 shares of the company’s stock valued at $381,000 after acquiring an additional 50 shares during the period. Northwestern Mutual Wealth Management Co. lifted its holdings in HCA Healthcare by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after acquiring an additional 143 shares during the period. Thrivent Financial For Lutherans lifted its holdings in HCA Healthcare by 1.5% in the second quarter. Thrivent Financial For Lutherans now owns 10,810 shares of the company’s stock valued at $943,000 after acquiring an additional 160 shares during the period. D.A. Davidson & CO. lifted its holdings in HCA Healthcare by 37.7% in the second quarter. D.A. Davidson & CO. now owns 1,970 shares of the company’s stock valued at $171,000 after acquiring an additional 539 shares during the period. Finally, Profund Advisors LLC lifted its holdings in HCA Healthcare by 5.2% in the second quarter. Profund Advisors LLC now owns 12,277 shares of the company’s stock valued at $1,071,000 after acquiring an additional 612 shares during the period. 75.35% of the stock is owned by institutional investors.

HCA has been the subject of a number of recent analyst reports. Credit Suisse Group reissued an “outperform” rating and issued a $25.00 target price on shares of HCA Healthcare in a report on Tuesday, December 26th. Robert W. Baird set a $104.00 target price on HCA Healthcare and gave the company a “buy” rating in a report on Friday, January 12th. Raymond James Financial downgraded HCA Healthcare from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, October 18th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 target price for the company. in a report on Wednesday, December 20th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $95.00 target price on shares of HCA Healthcare in a report on Friday, October 13th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and seventeen have given a buy rating to the company. HCA Healthcare has an average rating of “Buy” and a consensus price target of $88.32.

In related news, insider Michael S. Cuffe sold 2,400 shares of HCA Healthcare stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $86.63, for a total transaction of $207,912.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Victor L. Campbell sold 8,000 shares of HCA Healthcare stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $75.82, for a total value of $606,560.00. Following the sale, the senior vice president now owns 127,275 shares of the company’s stock, valued at approximately $9,649,990.50. The disclosure for this sale can be found here. In the last quarter, insiders have sold 20,550 shares of company stock valued at $1,606,172. 2.90% of the stock is currently owned by company insiders.

HCA Healthcare Inc (HCA) opened at $89.40 on Thursday. HCA Healthcare Inc has a 52-week low of $71.18 and a 52-week high of $91.03. The firm has a market capitalization of $31,436.32, a price-to-earnings ratio of 12.72, a PEG ratio of 1.17 and a beta of 0.55. The company has a debt-to-equity ratio of -6.46, a current ratio of 1.68 and a quick ratio of 1.41.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.21. HCA Healthcare had a negative return on equity of 47.16% and a net margin of 6.13%. The business had revenue of $10.70 billion during the quarter, compared to analysts’ expectations of $10.70 billion. During the same quarter last year, the business posted $1.45 earnings per share. The business’s revenue for the quarter was up 4.1% on a year-over-year basis. sell-side analysts forecast that HCA Healthcare Inc will post 6.56 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was first published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another website, it was stolen and reposted in violation of United States & international trademark & copyright law. The original version of this news story can be accessed at https://www.watchlistnews.com/hca-healthcare-inc-hca-holdings-reduced-by-gateway-investment-advisers-llc/1811839.html.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.